Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation-Reference-Cited by-同舟云学术

Effects of Amisulpride Adjunctive Therapy on Working Memory and Brain Metabolism in the Frontal Cortex of Patients with Schizophrenia: A Preliminary Positron Emission Tomography/Computerized Tomography Investigation

Published:2019-05-31 Issue:2 Volume:17 Page:250-260
ISSN:1738-1088
Container-title:Clinical Psychopharmacology and Neuroscience
language:en
Short-container-title:Clin Psychopharmacol Neurosci

Author:

Park Jeong Ha¹,Hong Ji Son¹,Kim Sun Mi¹,Min Kyung Joon¹,Chung Un Sun²,Han Doug Hyun¹^ORCID

Affiliation:

1. Department of Psychiatry, Chung-Ang University Hospital

2. Department of Psychiatry, Kyungpook National University Children’s

Publisher

Korean College of Neuropsychopharmacology

Subject

Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health

Link

http://pdf.medrang.co.kr/CPN2/2019/017/cpn017-02-11.pdf

Reference61 articles.

1. Schizophrenia: Moving Beyond Monoamine Antagonists

2. What are the functional consequences of neurocognitive deficits in schizophrenia?

3. The role of cognition in vocational functioning in schizophrenia

4. Cognitive Control Deficits in Schizophrenia: Mechanisms and Meaning

5. Cognitive Impairment in Schizophrenia Is the Core of the Disorder

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Amisulpride attenuates 5-fluorouracil-induced cognitive deficits via modulating hippocampal Wnt/GSK-3β/β-catenin signaling in Wistar rats;International Immunopharmacology;2023-11

2. Amisulpride augmentation therapy improves cognitive performance and psychopathology in clozapine-resistant treatment-refractory schizophrenia: a 12-week randomized, double-blind, placebo-controlled trial;Military Medical Research;2022-10-18

3. New Strategies to Improve Cognitive Symptom Domain in the Treatment of Schizophrenia;Psychosis and Personality Disorders;2022

4. Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia;Clinical Psychopharmacology and Neuroscience;2021-11-30

5. Consideration of Long-Acting Injectable Antipsychotics for Polypharmacy Regimen in the Treatment of Schizophrenia: Put It on the Table or Not?;Clinical Psychopharmacology and Neuroscience;2021-08-31